Hubei Goto Biopharm Group Co Ltd
300966
Company Profile
Business description
Hubei Goto Biopharm Group Co Ltd is engaged in the research, development, production and sales of steroidal drug raw materials. The company's main products are starting materials, intermediates and active pharmaceutical ingredients required for the production of steroid drugs.
Contact
Jiangshan South Road, Wolong Avenue
33rd Floor, Building 1, Global Financial City
Fancheng District, Hubei Province
Xiangyang441057
CHNT: +86 7103523126
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
893
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,715.67 | 0.74 | 0.01% |
| DAX 40 | 26,339.59 | 20.14 | 0.08% |
| Dow JONES (US) | 54,005.94 | 30.99 | -0.06% |
| FTSE 100 | 10,853.07 | 48.02 | -0.44% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,707.30 | 16.69 | 0.06% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,770.39 | 12.75 | 0.16% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |